You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Claims for Patent: 10,543,219

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,543,219

Title:	Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Abstract:	A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
Inventor(s):	Dudley; Robert E. (Murfreesboro, TN), Constantinides; Panayiotis P. (Gurnee, IL)
Assignee:	Clarus Therapeutics, Inc. (Northbrook, IL)
Application Number:	15/723,985
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,543,219
Patent Claims:	1. A method of treating testosterone deficiency or its symptoms in a male in need thereof comprising: daily administering to said male about 475 mg testosterone undecanoate, wherein said testosterone undecanoate is administered in an oral pharmaceutical composition with food, and wherein said oral pharmaceutical composition comprises: 18-22 percent by weight of solubilized testosterone undecanoate; 50-55 percent by weight of oleic acid; 15-17 percent by weight of polyoxyethylene (40) hydrogenated castor oil; and 10-15 percent by weight of a mixture of borage seed oil and peppermint oil. 2. The method of claim 1, wherein said oral pharmaceutical composition comprises about 20 percent by weight testosterone undecanoate. 3. The method of claim 1, wherein said oral pharmaceutical composition comprises: 19.8 percent by weight of solubilized testosterone undecanoate; 51.6 percent by weight of oleic acid; 16.1 percent by weight of polyoxyethylene (40) hydrogenated castor oil; 10 percent by weight of borage seed oil; and 2.5 percent by weight of peppermint oil. 4. The method of claim 3, wherein said oral pharmaceutical composition further comprises one or more antioxidants. 5. The method of claim 1, wherein said oral pharmaceutical composition is in the form of a capsule. 6. The method of claim 1, wherein said administration results in a serum testosterone C.sub.ave in said male in the range of from about 300-1100 ng/dL. 7. The method of claim 1, wherein said oral pharmaceutical composition is administered once daily. 8. The method of claim 1, wherein said oral pharmaceutical composition is administered twice daily. 9. The method of claim 8, wherein said administration results in a serum testosterone C.sub.ave in said male in the range of from about 300-1100 ng/dL. 10. The method of claim 1, wherein said male has primary hypogonadism. 11. A method of treating testosterone deficiency or its symptoms in a male having primary hypogonadism comprising: daily administering to said male about 475 mg testosterone undecanoate, wherein said testosterone undecanoate is administered in an oral pharmaceutical composition, and wherein said oral pharmaceutical composition is administered twice daily with food and comprises: 19.8 percent by weight of solubilized testosterone undecanoate; 51.6 percent by weight of oleic acid; 16.1 percent by weight of polyoxyethylene (40) hydrogenated castor oil; 10 percent by weight of borage seed oil; and 2.5 percent by weight of peppermint oil. 12. The method of claim 11, wherein said administration results in a serum testosterone C.sub.ave in said male in the range of from about 300-1100 ng/dL.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.